Asset Management One
ALDR

Asset Management One’s Alder Biopharmaceuticals ALDR Stock Holding History

Asset Management One’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-309,500
Closed -$9.69M – 1319
2016
Q3 		$9.69M Sell
309,500
-75,940
-20% -$2.31M 0.14% 158
2016
Q2 		$9.38M Sell
385,440
-20,099
-5% -$544K 0.14% 164
2016
Q1 		$9.47M Buy
405,539
+44,614
+12% +$1.03M 0.14% 160
2015
Q4 		$12.5M Buy
360,925
+91,487
+34% +$3.09M 0.19% 130
2015
Q3 		$7.92M Buy
269,438
+163,134
+153% +$6.94M 0.12% 208
2015
Q2 		$4.99M Buy
+106,304
New +$3.87M 0.07% 363

Other funds holding ALDR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return